Table 1 Patients’ characteristics and clinical outcomes (n = 117).
From: Impact of physiologically shaped pancreatic stent for chronic pancreatitis
Gender, male/female | 100/17 |
Age, median (range) | 67 (28–83) |
Etiology*, alcoholic/idiopathic/post operation/tumor | 70/32/12/3 |
Diameter of pancreatic stent, Fr, 5/7/8.5/10 | 11/40/30/36 |
Length of pancreatic stent, centimeter, ≤ 5/6–7/8–9/ ≤ 10 | 18/77/16/6 |
Stent patency rate at 90 days, %, (n) | 60.7% (71/117) |
Stent-related adverse eventa within 90 days, n (%) | 46 (39.3) |
Occlusion/proximal stent migration/distal stent migration/other | 41/2/2/1 |
